CEACAM5 and neoplasm: Circulating tumour markers as Carcinoembryonic Antigen (CEA) and Cancer Antigen 15-3 (CA 15-3) have become well established diagnostic tools as fast, non-invasive, reproducible and quantitative parameters in follow-up care and monitoring therapy of breast cancer patients.